SNN

Smith & Nephew plc
D

SNN

28.160
USD
-0.22
(-0.76%)
Market Open
Volume
6,447
EPS
2
Div Yield
2.64
P/E
30
Market Cap
12,299,022,264
Related Instruments
ABT
ABT
-1.150
(-0.87%)
131.430 USD
BAX
BAX
-0.260
(-0.76%)
33.970 USD
BDX
BDX
-2.570
(-1.12%)
226.500 USD
BSX
BSX
-0.190
(-0.19%)
100.600 USD
EW
EW
-0.700
(-0.97%)
71.760 USD
ILMN
ILMN
-1.120
(-1.41%)
78.210 USD
ISRG
ISRG
-3.99
(-0.81%)
489.96 USD
MDT
MDT
-1.445
(-1.61%)
88.320 USD
PODD
PODD
0.39
(0.15%)
262.94 USD
TMO
TMO
-11.34
(-2.28%)
484.85 USD
More
News

Title: Smith & Nephew plc

Sector: Healthcare
Industry: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.